HAVCR2 and non-small cell lung carcinoma: Lu et al. [29] demonstrated that although TIM-3 and LAG-3 expression on CD3+ T cells was lower in NSCLC brain metastases compared with primary lung tumors, their expression was nevertheless associated with improved overall survival.